Mutations associated with hemophilia A in the 558-565 loop of the factor VIIIa A2 subunit alter the catalytic activity of the factor Xase complex
- 15 July 2002
- journal article
- Published by American Society of Hematology in Blood
- Vol. 100 (2), 501-508
- https://doi.org/10.1182/blood-2001-12-0361
Abstract
The 558-565 loop region in the A2 subunit of factor (F) VIIIa forms a direct interface with FIXa. We have expressed and purified B-domainless FVIII (FVIIIWT) and B-domainless FVIII containing the hemophilia A–associated mutations Ser558Phe, Val559Ala, Asp560Ala, Gln565Arg, and the activated protein C cleavage site mutant Arg562Ala. Titration of FVIIIa in FXa generation assays showed that the mutant and wild-type proteins had similar functional affinities for FIXa (dissociation constant [Kd] values ∼5 nM-20 nM and ∼100 nM-250 nM in the presence and absence of phospholipid, respectively). The catalytic activities of the factor Xase complex composed of the hemophilia A–associated FVIII species were markedly reduced both in the presence and absence of phospholipid. FVIIIWT and FVIIIArg562Ala showed catalytic rate constant (kcat) values of approximately 60 minute−1 in the presence of phospholipid, whereas the hemophilia A–associated mutants showedkcat values ranging from 3.3 minute−1 to 7.5 minute−1. In the absence of phospholipid, all kcat values were reduced but FVIIIWT and FVIIIArg562Ala retained higher activities as compared with the hemophilic mutant FVIII forms. Fluorescence anisotropy experiments using fluorescein-modified FIXa confirmed that all FVIII forms interacted with FIXa. However, the presence of factor X yielded minimal increases in anisotropy observed with the mutant factor VIII forms, consistent with their reduced activity. These results show that residues within the 558-565 loop are critical in modulating FIXa enzymatic activity but do not contribute significantly to the affinity of FVIIIa for FIXa.Keywords
This publication has 38 references indexed in Scilit:
- The Life Cycle of Coagulation Factor VIII in View of Its Structure and FunctionBlood, 1998
- The coagulation cascade: initiation, maintenance, and regulationBiochemistry, 1991
- Human factor VIIIa subunit structure. Reconstruction of factor VIIIa from the isolated A1/A3-C1-C2 dimer and A2 subunitPublished by Elsevier ,1991
- Subunit structure of thrombin-activated porcine factor VIIIBiochemistry, 1989
- A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity.Proceedings of the National Academy of Sciences, 1986
- The size of human factor VIII heterodimers and the effects produced by thrombinBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1986
- Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.Proceedings of the National Academy of Sciences, 1986
- Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activityBiochemistry, 1986
- Expression of active human factor VIII from recombinant DNA clonesNature, 1984
- Monoclonal antibodies to porcine factor VIII coagulant and their use in the isolation of active coagulant proteinBlood, 1982